John Allen Mccutchan
#164,807
Most Influential Person Now
John Allen Mccutchan's AcademicInfluence.com Rankings
John Allen Mccutchanphilosophy Degrees
Philosophy
#9649
World Rank
#13238
Historical Rank
Logic
#6618
World Rank
#8151
Historical Rank
John Allen Mccutchanbiology Degrees
Biology
#13287
World Rank
#16827
Historical Rank
Immunology
#915
World Rank
#938
Historical Rank
Download Badge
Philosophy Biology
John Allen Mccutchan's Degrees
- Masters Medicine University of California, San Francisco
- PhD Immunology University of California, San Francisco
Why Is John Allen Mccutchan Influential?
(Suggest an Edit or Addition)John Allen Mccutchan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy (2010) (1694)
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors (2010) (1385)
- Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. (2008) (808)
- The impact of HIV-associated neuropsychological impairment on everyday functioning (2004) (690)
- The HNRC 500-Neuropsychology of Hiv infection at different disease stages (1995) (661)
- Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. (1987) (570)
- The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. (1999) (569)
- Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders (1997) (485)
- Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. (1988) (370)
- PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID (1985) (360)
- CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy (2011) (357)
- Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. (1983) (336)
- Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. (2020) (335)
- Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. (1996) (332)
- Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome (1997) (332)
- Neurologic complications of HIV disease and their treatment. (2010) (326)
- Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. (2015) (308)
- Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy (2009) (278)
- Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline (2014) (242)
- Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders (2004) (236)
- A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. (1991) (234)
- Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. (1997) (218)
- Neuropsychological impairment in human immunodeficiency virus‐infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. (1994) (209)
- Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources (2000) (200)
- Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. (1994) (186)
- Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. (1991) (186)
- Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. (1992) (184)
- Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. (1998) (182)
- Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group. (1990) (180)
- Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. (1990) (179)
- Clinical factors related to brain structure in HIV: the CHARTER study (2011) (167)
- Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder (2012) (166)
- Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. (1990) (161)
- Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. (2002) (159)
- Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy (2002) (156)
- Identification of psychobiological stressors among HIV-positive women. HIV Neurobehavioral Research Center (HNRC) Group. (1993) (154)
- HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. (2010) (153)
- Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. (1990) (147)
- Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy (2005) (146)
- Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors (2005) (145)
- Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome (1987) (140)
- Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change (2011) (139)
- Magnetic Resonance Imaging Morphometric Analysis of Cerebral Volume Loss in Human Immunodeficiency Virus Infection (1993) (136)
- Relationship of psychosocial factors to HIV disease progression (1996) (133)
- Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group. (1989) (130)
- Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection. (1995) (129)
- Low atazanavir concentrations in cerebrospinal fluid (2009) (127)
- The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease (2005) (125)
- Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group. (1992) (124)
- Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. (1990) (122)
- Incidence of and Risk Factors for Clinically Significant Methicillin-Resistant Staphylococcus aureus Infection in a Cohort of HIV-Infected Adults (2005) (122)
- Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia. (1977) (120)
- Patterns of Selective Neuronal Damage in Methamphetamine-User AIDS Patients (2003) (119)
- Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. (2004) (118)
- Neurocognitive Impact of Substance Use in HIV Infection (2011) (117)
- Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. (2014) (114)
- Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial. (2003) (108)
- Genetic attributes of cerebrospinal fluid-derived HIV-1 env. (2006) (105)
- Cerebrospinal Fluid β Chemokine Concentrations in Neurocognitively Impaired Individuals Infected with Human Immunodeficiency Virus Type 1 (1999) (104)
- Two-year prospective study of major depressive disorder in HIV-infected men. (2008) (104)
- National estimates of HIV-related symptom prevalence from the HIV Cost and Services Utilization Study. (2000) (103)
- Validity of the Quality of Well-Being Scale for Persons With Human Immunodeficiency Virus Infection (1995) (98)
- Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. (2003) (98)
- A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus. (1993) (97)
- Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. (2011) (97)
- The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis (2002) (93)
- A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis (2009) (92)
- Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy (2008) (88)
- Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum. (1975) (88)
- Cytomegalovirus infections of the nervous system in patients with AIDS. (1995) (85)
- Acquired immunodeficiency syndrome. Magnetic resonance patterns of brain involvement with pathologic correlation. (1988) (84)
- HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon (2010) (83)
- HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients (2007) (81)
- Lifetime suicidal ideation and attempt are common among HIV+ individuals. (2012) (81)
- Low Cerebrospinal Fluid Concentrations of the Nucleotide HIV Reverse Transcriptase Inhibitor, Tenofovir (2012) (78)
- The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. (1989) (77)
- Transforming growth factor-beta and suppression of humoral immune responses in HIV infection. (1991) (76)
- Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. (1998) (76)
- Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group. (1995) (76)
- Use of and Adherence to Antiretroviral Therapy Is Associated With Decreased Sexual Risk Behavior in HIV Clinic Patients (2005) (74)
- Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. (2003) (74)
- Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis. (2008) (73)
- Role of blocking antibody in disseminated gonococcal infection. (1978) (73)
- A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group. (1997) (73)
- Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. (1993) (70)
- Cryptosporidiosis of the stomach and small intestine in patients with AIDS. (1984) (70)
- A factor analysis of the Klein sexual orientation Grid in two disparate samples (1993) (69)
- White matter damage, neuroinflammation, and neuronal integrity in HAND (2018) (68)
- Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease. (1992) (67)
- Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation (2015) (67)
- High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group. (1994) (66)
- Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients (2011) (65)
- Autopsy findings in AIDS patients with Mycobacterium avium complex bacteremia. (1994) (65)
- Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy (2017) (63)
- Ineffectiveness of single-dose human antiserum to core glycolipid (E. coli J5) for prophylaxis of bacteremic, gram-negative infections in patients with prolonged neutropenia. (1983) (61)
- Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae. (1979) (60)
- Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. (1999) (59)
- Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors (2001) (58)
- Stress and Depressive Symptoms Prospectively Predict Immune Change among HIV-Seropositive Men. (1995) (58)
- AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy. (2001) (58)
- Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection (1987) (57)
- Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders (2013) (57)
- Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages (1993) (57)
- Indinavir Population Pharmacokinetics in Plasma and Cerebrospinal Fluid (2000) (56)
- T-cell-induced expression of human immunodeficiency virus in macrophages (1990) (55)
- HAEMOPHILUS PARAINFLUENZAE INFECTIVE ENDOCARDITIS (1977) (55)
- Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission. (1982) (55)
- Population Pharmacokinetics of Abacavir in Plasma and Cerebrospinal Fluid (2005) (55)
- Influence of colony type on susceptibility of gonococci to killing by human serum. (1976) (54)
- Lopinavir with Ritonavir Reduces the HIV RNA Level in Cerebrospinal Fluid (2007) (54)
- Effects of recalled childhood gender nonconformity on adult genitoerotic role and AIDS exposure (1992) (54)
- Identification of Cryptosporidium in patients with the acquired immunodeficiency syndrome. (1983) (53)
- Neuropsychological performance of HIV-1 infected men with major depression (1997) (52)
- Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort. (1992) (51)
- Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. The HIV Neurobehavioral Research Center Group. (1993) (51)
- Alternative Regimens for the Prophylaxis of Mycobacterium avium Complex in Acquired Immune Deficiency Syndrome (AIDS) (1997) (51)
- Review of medical microbiology (1983) (51)
- Do Patients With HIV-Associated Minor Cognitive/Motor Disorder Exhibit a “Subcortical” Memory Profile? Evidence Using the California Verbal Learning Test (1995) (50)
- A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575 (2005) (48)
- A Randomized Controlled Trial of Therapeutic Drug Monitoring in Treatment-Naive and -Experienced HIV-1-Infected Patients (2007) (48)
- Relationships Among Neurocognitive Status, Medication Adherence Measured by Pharmacy Refill Records, and Virologic Suppression in HIV-Infected Persons (2013) (48)
- Epidemiology of venereal urethritis: comparison of gonorrhea and nongonococcal urethritis. (1984) (45)
- Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy (2010) (44)
- Psychiatric Context of Acute/Early HIV Infection. The NIMH Multisite Acute HIV Infection Study: IV (2009) (44)
- Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection (2013) (43)
- CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease (2015) (41)
- The Role of Cohort Studies in Drug Development: Clinical Evidence of Antiviral Activity of Serotonin Reuptake Inhibitors and HMG-CoA Reductase Inhibitors in the Central Nervous System (2007) (41)
- Neurocognitive impairment in HIV-infected individuals with previous syphilis (2013) (41)
- Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment. (1983) (40)
- The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. (1991) (39)
- Disseminated Mycobacterium avium complex: correlation between blood and tissue burden. (1996) (39)
- The relationship between loneliness, interpersonal competence, and immunologic status in hiv-infected men (1994) (38)
- Detecting human immunodeficiency virus RNA in peripheral blood mononuclear cells by nucleic acid hybridization. (1987) (38)
- Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. (1993) (38)
- Endoscopic diagnosis and management of hepatobiliary tuberculosis. (1996) (38)
- Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans (1998) (37)
- A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l (2001) (36)
- Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS. (1995) (36)
- Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. (1991) (35)
- Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy (2011) (35)
- Is gender dysphoria dysphoric? Elevated depression and anxiety in gender dysphoric and nondysphoric homosexual and bisexual men in an HIV sample (1995) (35)
- A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy. (2001) (34)
- Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects (2019) (33)
- Effects of comorbidity burden and age on brain integrity in HIV (2019) (33)
- Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration. (2013) (33)
- Testicular pathologic changes and the pituitary-testicular axis during human immunodeficiency virus infection. (1999) (32)
- Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial (1999) (32)
- Neuroleptic Treatment of HIV-Associated Psychosis (1994) (31)
- Relationship of Medication Management Test-Revised (MMT-R) Performance to Neuropsychological Functioning and Antiretroviral Adherence in Adults with HIV (2012) (30)
- Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining “symptomatic” versus “asymptomatic” HAND (2017) (30)
- Immunization against nosocomial infection. (1981) (30)
- Etravirine in CSF is highly protein bound. (2013) (30)
- Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era. (2016) (29)
- Unmasking of PML by HAART: Unusual clinical features and the role of IRIS (2010) (29)
- The Correlation between Plasma Concentrations of Protease Inhibitors, Medication Adherence and Virological Outcome in HIV-Infected Patients (2004) (28)
- Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States (2017) (28)
- Genetic Variation in Iron Metabolism Is Associated with Neuropathic Pain and Pain Severity in HIV-Infected Patients on Antiretroviral Therapy (2014) (28)
- Role of metabolic syndrome components in HIV-associated sensory neuropathy (2009) (28)
- Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center. (1996) (27)
- Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis (1992) (27)
- HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter (2014) (27)
- Genome‐wide association study of HIV‐associated neurocognitive disorder (HAND): A CHARTER group study (2017) (26)
- Concurrent Classification Accuracy of the HIV Dementia Scale for HIV-Associated Neurocognitive Disorders in the CHARTER Cohort (2013) (26)
- Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER (2012) (25)
- Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection (2018) (25)
- Liver histology and diffusion‐weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study (2017) (25)
- Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection. (2015) (25)
- Gallbladder and bile duct abnormalities in AIDS: sonographic findings in eight patients. (1988) (25)
- The influence of HIV-related support groups on survival in women who lived with HIV. A pilot study. (2000) (24)
- The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. California Collaborative Treatment Group. (1995) (24)
- Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy (2006) (24)
- Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis. (1995) (23)
- Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates (2019) (23)
- Role of metabolic syndrome components in human immunodeficiency virus-associated stroke (2009) (23)
- Evaluation of new anti-infective drugs for the treatment of uncomplicated gonorrhea in adults and adolescents. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (23)
- Human Immunodeficiency Virus-Associated Neurobehavioural Disorder (1988) (21)
- Depressive Symptoms Among HIV Positive Men: Life Stress, Coping, and Social Support1 (1993) (21)
- Evaluation of new anti-infective drugs for the treatment of syphilis. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (21)
- Corticosteroids as adjunctive therapy for Pneumocystis pneumonia in patients with AIDS. (1991) (21)
- Disseminated Gonococcal Infection in Mice (1979) (20)
- Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration (2012) (19)
- CMV-specific immune responses and HLA phenotypes of AIDS patients who develop CMV retinitis. HNRC Group. HIV Neurobehavioral Research Center. (1994) (19)
- Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection (2011) (19)
- Sensory testing in human immunodeficiency virus type 1-infected men. HIV Neurobehavioral Research Center Group. (1992) (18)
- Low CSF Leptin Levels are Associated with Worse Learning and Memory Performance in HIV-infected Men (2007) (18)
- Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment (2001) (18)
- Virology, immunology, and clinical course of HIV infection. (1990) (18)
- Therapeutic Amprenavir Concentrations in Cerebrospinal Fluid (2012) (18)
- Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat (2012) (16)
- Penetration and Effectiveness of Antiretroviral Therapy in the Central Nervous System (2009) (16)
- Neurological Symptoms, Not Signs,Are Common in Early HIV Infection. (1996) (15)
- Role of urinary solutes in natural immunity to gonorrhea (1977) (15)
- Prevalence and risk factors for HIV CSF Viral Escape: Results from the CHARTER and HNRP cohorts (2012) (15)
- Antiserum treatment of gram-negative bacteremia. (1978) (15)
- Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States. (2001) (15)
- Treatment of gram-negative bacteremia with antiserum to core glycolipid. I. The experimental basis of immunity to endotoxin. (1979) (14)
- Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy. (2003) (14)
- Cognitive Impairment in Zambians With HIV Infection and Pulmonary Tuberculosis (2019) (14)
- Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. (2019) (14)
- Marked elevation of the serum ferritin is highly specific for disseminated histoplasmosis in AIDS. (1995) (13)
- HIV-1 neurocognitive disorders and chemokine receptors. (1997) (13)
- Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners (2019) (13)
- Meeting Practical Challenges of a Trial Involving a Multitude of Treatment Regimens: An Example of a Multi-Center Randomized Controlled Clinical Trial in NeuroAIDS (2007) (13)
- Neurologic complications of HIV disease and their treatment. (2009) (13)
- Retinal findings and characteristics in AIDS patients with systemic Mycobacterium avium-intracellulare complex and toxoplasmic encephalitis. (1997) (12)
- Cluster Analysis of the Klein Sexual Orientation Grid in Clinical and Nonclinical Samples: When Bisexuality Is Not Bisexuality (2014) (12)
- Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals (2016) (12)
- Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus. (1993) (12)
- Rhabdomyolysis and Staphylococcus aureus septicemia in a man with the acquired immunodeficiency syndrome. (1990) (12)
- Differentiation of neisseriaceae by isoenzyme electrophoresis. (1983) (12)
- The Relationship Between Neuropsychological Functioning and Coping Activity Among HIV-Positive Men (1997) (11)
- The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk (2014) (11)
- HIV‐1 ASSOCIATED NEUROCOGNITIVE DISORDER (1992) (11)
- Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. (2012) (11)
- Social and psychological characteristics of HIV-infected women and gay men. HIV Neurobehavioral Research Center (HNRC) Group. (1996) (11)
- Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study. (2019) (11)
- Treatment of gram-negative bacteremia with antiserum to core glycolipid II. A controlled trial of antiserum in patients with bacteremia. (1979) (11)
- Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV (2020) (10)
- An open label, phase I/II clinical trial to evaluate the safety and biological activity of HIV-IT (V) (HIV-1IIIBenv/rev retroviral vector) in HIV-1-infected subjects. (1995) (10)
- Human Immunodeficiency Virus Replication in AIDS Patients with Mycobacterium avium Complex Bacteremia: A Case Control Study (1998) (10)
- Prevalence of Psychiatric Disorders Among Men Infected With Human Immunodeficiency Virus (2015) (10)
- Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities (2019) (10)
- Successful treatment of human gram-negative bacteremia with antiserum against endotoxin core. (1981) (9)
- Brain morphometric correlates of metabolic variables in HIV: the CHARTER study (2014) (9)
- Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. (1999) (9)
- Evaluation of new anti-infective drugs for the treatment of vaginal infections. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (9)
- Symptom-based framework for assessing quality of HIV care. (2004) (9)
- Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Neurologic complications of HIV disease and their treatment. (2008) (9)
- Prevalence and Risk Factors for Human Immunodeficiency Virus (HIV) and Syphilis Infections Among Military Personnel in Sierra Leone. (2017) (9)
- Characterizing HIV Medication Adherence for Virologic Success Among Individuals Living With HIV/AIDS: Experience With the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Cohort (2014) (8)
- Knowledge, Attitudes, and Practice Regarding Research Ethics Committees Among Health Care Faculty at Two Public Universities in Jordan (2019) (8)
- Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. (2011) (8)
- TREATMENT WITH ANTI-GRAM-NEGATIVE ANTIBODIES (1983) (8)
- Plaque Assay for Measuring Serum Bactericidal Activity Against Gonococci (1978) (8)
- Deficiency of erythrocyte C3b receptor (CR1) in AIDS and AIDS-related syndromes (1986) (7)
- Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus (1989) (7)
- Brief Report: Body Mass Index and Cognitive Function Among HIV-1–Infected Individuals in China, India, and Nigeria (2019) (7)
- Neuroleptic treatment of HIV-associated psychosis. HNRC group. (1994) (7)
- COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk for Neurocognitive Impairment in Men Living with HIV. (2019) (7)
- Evaluation of new anti-infective drugs for the treatment of genital infections due to herpes simplex virus. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (6)
- Improved tuberculosis smear detection in resource-limited settings: Combined bleach concentration and LED fluorescence microscopy. (2011) (6)
- Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease. (2000) (6)
- The impact of concomitant viral pathogens on the course of Pneumocystis carinii pneumonia. (1991) (6)
- Management of HIV in resource limited settings (2009) (5)
- Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia. (2016) (5)
- Neuroleptic Treatment of HIV-Associated Psychosis (1994) (5)
- Treatment of acute toxoplasmosis with intravenous clindamycin (1991) (5)
- Evaluation of new anti-infective drugs for the treatment of chancroid. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (5)
- Common heat stable protective antigen in gonococci. (1979) (5)
- PREVENTING DEATH FROM SHOCK BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID (1985) (5)
- Bartonella henselae serostatus is not correlated with neurocognitive decline in HIV infection. (2001) (4)
- Cerebrospinal Fluid b Chemokine Concentrations in Neurocognitively Impaired Individuals Infected with Human Immunodeficiency Virus Type 1 (1999) (4)
- Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. HIV Neurobehavioral Research Center Group. (1995) (4)
- HIV-1 associated neurocognitive disorder. The HNRC Group. (1992) (4)
- Survey of cases of gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae in the United Kingdom. (1985) (4)
- Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individuals. (1994) (4)
- Paresthesia Predicts Increased Risk of Distal Neuropathic Pain in Older People with HIV-Associated Sensory Polyneuropathy. (2021) (3)
- Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders (2013) (3)
- Evaluation of new anti-infective drugs for the treatment of sexually transmitted chlamydial infections and related clinical syndromes. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (3)
- The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era (2004) (3)
- Associations Among Coping Style, Personality, Unsafe Sexual Behavior, Depression, Conflict over Sexual Orientation, and Gender Nonconformity (1995) (3)
- The HIV epidemic: medical and social challenges. (1989) (2)
- Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group. (1991) (2)
- Human immunodeficiency virus replication in AIDS patients with Mycobacterium avium complex bacteremia: a case control study. California Collaborative Treatment Group. (1998) (2)
- Altered Erythrocyte C 3 b Receptor Expression , Immune Complexes , and Complement Activation in Homosexual Men in Varying Risk Groups for Acquired Immune Deficiency Syndrome (2013) (2)
- Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV (2022) (1)
- Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years (2022) (1)
- Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances (2020) (1)
- Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study. (2022) (1)
- Attitudes toward early detection of infection by the AIDS retrovirus among persons at high and low risk (1993) (1)
- Collaborative multidisciplinary workshop report (2000) (1)
- Azithromycin in the prophylaxis of opportunistic infections in AIDS (1996) (1)
- Immunoprophylaxis and immunotherapy of Gram-negative infections in the immunocompromised host. (1984) (1)
- Special issues in clinical trials of new anti-infective drugs for the treatment of sexually transmitted diseases. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (1)
- Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat (2012) (0)
- Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
- Pharmacology of Antiretroviral Therapies (2011) (0)
- Reply to Haddow et al. (2015) (0)
- Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals (2016) (0)
- Prevalence of and risk factors for Human Immunodeficiency Virus (HIV) infection in entrants and residents of an Ethiopian prison (2023) (0)
- White matter damage, neuroinflammation, and neuronal integrity in HAND (2018) (0)
- Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection (2018) (0)
- Intact Families with a Multiple Sclerotic Parent: Social and Emotional Adjustment of Parents and School-Age Children (1994) (0)
- Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection (2013) (0)
- Antibody toaSynthetic Oligopeptide inSubjects atRiskfor HumanImmunodeficiency Virus Infection RICHARDS.SMITH,'* ROBERTB.NASO,1JONROSEN,' ALICEWHALLEY,' YAO-LINGHOM,'KENWAY (1987) (0)
- 59-1 Neurocognitive disturbances in HIV, including HIV-assoclated dementia (1997) (0)
- Higher levels of cerebrospinal fluid and plasma neurofilament light in human immunodeficiency virus-associated distal sensory polyneuropathy. (2022) (0)
- HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter (2014) (0)
- Better Biomarkers Are Needed to Improve the Management of the Neurologic Complications of HIV Infection (2008) (0)
- Internal medicine-important advances in clinical medicine: acquired immune deficiency syndrome (AIDS). (1983) (0)
- Erratum to: Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria (2012) (0)
- Asymptomatic Malaria Co-infection of HIV-infected Adults in Nigeria: Prevalence of and Impact on Cognition, Mood and Biomarkers of Systemic Inflammation. (2020) (0)
- Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial (1991) (0)
- Anemia and Erythrocyte Indices Are Associated With Neurocognitive Performance Across Multiple Ability Domains in Adults With HIV (2022) (0)
- Internal medicine-epitomes of progress: characteristics of gonococci which disseminate in the blood. (1978) (0)
- Erratum to: Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria (2012) (0)
- Letter from J. Allen McCutchan, University of California, San Diego Medical Center to Harold Varmus (1985) (0)
- Reply (1998) (0)
- Brain morphometric correlates of metabolic variables in HIV: the CHARTER study (2014) (0)
- Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining “symptomatic” versus “asymptomatic” HAND (2016) (0)
- Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV: A Latent Growth Mixture Model (2021) (0)
- CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease (2015) (0)
- Title Correlation of in Vivo Neuroimaging Abnormalities with Postmortem Human Immunodeficiency Virus Encephalitis and Dendritic Loss Permalink (2004) (0)
- Internal medicine: antibody testing for the AIDS retrovirus-implications for clinicians. (1985) (0)
- Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER (2012) (0)
- Contents of the American Journal of Psychiatry (1992) (0)
- What you can do to stop the AIDS panic. (1986) (0)
- A-03 Ethnic/Racial Differences in Longitudinal Neurocognitive Change among People Living with HIV (2019) (0)
This paper list is powered by the following services:
